Darunavir: In Treatment-Experienced Pediatric Patients with HIV-1 Infection

By McKeage Kate   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

By Mehandru Saurabh   Markowitz Martin  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1821-1828

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen   Morelló Judit   Garcia-Gascó Pilar   Rodríguez-Novoa Sonia   Soriano Vincent  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection: Rationale and Results

By Taiwo Babafemi   Murphy Robert L.   Katlama Christine  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1629-1642

Adis International

Access to resources Recommend Favorite

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite